IDIFARMA is authorized as a GMP manufacturer for both investigational medicinal products and human use medicinal products.

IDIFARMA’s approach to the CMO services is very specialized, because of our capability to manufacture highly potent drugs (cytotoxics…) and due to our small and flexible manufacturing plant, with a maximum batch size of 60 Kg. This turns IDIFARMA into a very suitable solution for niche medicinal products.

Our current authorization for investigational medicinal products allows us to manufacturer clinical batches in the following dosage forms: tablets (immediate or modified release), hard capsules and powders for oral use. For more information, check the “Clinical Batches” section in our website.

We are also GMP certified to manufacture commercial batches in tables, both immediate and modified release. For more information about our capabilities as a CMO, please visit the Commercial Batches section.

In addition, we can also perform primary and secondary packaging activities.

You can download our updated GMP certification here.